Page last updated: 2024-08-25

dehydrocostus lactone and dinoprostone

dehydrocostus lactone has been researched along with dinoprostone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Chang, KC; Kim, HJ; Kwak, JH; Lee, DU; Park, EJ; Park, SW1

Other Studies

2 other study(ies) available for dehydrocostus lactone and dinoprostone

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Dehydrocostuslactone inhibits LPS-induced inflammation by p38MAPK-dependent induction of hemeoxygenase-1 in vitro and improves survival of mice in CLP-induced sepsis in vivo.
    International immunopharmacology, 2014, Volume: 22, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Cecum; Cell Line; Cell Survival; Dinoprostone; Gene Silencing; Heme Oxygenase-1; Lactones; Ligation; Lipopolysaccharides; Liver; Lung; Macrophages; Membrane Proteins; Mice; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Sepsis; Sesquiterpenes

2014